< Back to all clusters
[POLITICS] · United States · 21 sources

started · updated

Heidi Overton faces Senate hearing for FDA commissioner nomination

Dr. Heidi Overton, President Donald Trump’s nominee for FDA Commissioner, appeared before the Senate Health, Education, Labor, and Pensions Committee for a confirmation hearing. During the proceedings, Overton addressed several contentious issues, including childhood vaccination schedules and the safety of the abortion drug mifepristone.

Overton testified that all vaccines currently on the U.S. market are safe and effective, specifically endorsing the measles, mumps, and rubella (MMR) vaccine. This statement appeared to diverge from recent rhetoric from President Trump, who has characterized the combined MMR vaccine as “quite lethal.” Despite her testimony, senators questioned her previous support for an executive order aimed at spacing out childhood vaccinations.

Regarding mifepristone, Overton stated the drug has met FDA safety and efficacy standards. This comes amid pressure from pro-life advocates to restore previous restrictions on the medication. Additionally, Overton expressed a desire to increase FDA efficiency to better compete with China’s biotechnology sector and discussed potential regulatory changes regarding flavored electronic cigarettes.

Entities

Bill Cassidy · China · Donald Trump · Food and Drug Administration · Heidi Overton · Senate Health, Education, Labor and Pensions Committee · Susan Collins

Claims

What the coverage asserts, and how many sources carry each claim.

Sources

about 6 hours ago
about 23 hours ago